Cargando…
Rituximab-Induced Kaposi Sarcoma in HIV-Negative Patients: A Narrative Review
Kaposi sarcoma (KS) is a low-grade mesenchymal angioproliferative disorder that requires infection with human herpes virus 8 (HHV-8) for it to develop. It is commonly seen in HIV-positive patients and rarely in immunosuppressed HIV-negative patients. Rituximab is a monoclonal anti-CD20 chimeric muri...
Autores principales: | Oprita, Alexandru, Cotan, Horia, Celmare, Dana, Emilescu, Radu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578454/ https://www.ncbi.nlm.nih.gov/pubmed/37849608 http://dx.doi.org/10.7759/cureus.45365 |
Ejemplares similares
-
HIV-Associated Cutaneous Kaposi's Sarcoma
por: Alluhaybi, Abdulrahman F, et al.
Publicado: (2021) -
Kaposi Sarcoma in an Immunocompetent Patient Treated With Paclitaxel
por: Sharma, Sunakshi, et al.
Publicado: (2023) -
Kaposi Sarcoma: A Rare Presentation of Elephantiasis Nostras Verrucosa
por: Doodnauth, Andrew V, et al.
Publicado: (2023) -
Human Herpesvirus 8 (HHV-8) Staining: A Savior in Early Kaposi Sarcoma
por: Siddiqui, Farhan, et al.
Publicado: (2023) -
Pathology of rituximab-induced Kaposi sarcoma flare
por: Pantanowitz, Liron, et al.
Publicado: (2008)